Albuterol Nebulizer Order for Asthma
For adults with acute asthma exacerbation, order albuterol 2.5–5 mg via nebulizer every 20 minutes for 3 doses, then 2.5–10 mg every 1–4 hours as needed; for children, use 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses, then 0.15–0.3 mg/kg every 1–4 hours as needed. 1
Standard Order Components
Adult Dosing
- Initial treatment (first hour): Albuterol 2.5–5 mg via nebulizer every 20 minutes × 3 doses 1
- Maintenance dosing: Albuterol 2.5–10 mg via nebulizer every 1–4 hours as needed based on clinical response 1
- Severe exacerbations: Consider continuous nebulization at 10–15 mg/hour for patients with severe obstruction or inadequate response to intermittent dosing 1
Pediatric Dosing
- Initial treatment: Albuterol 0.15 mg/kg (minimum 2.5 mg) via nebulizer every 20 minutes × 3 doses 1, 2
- Maintenance dosing: Albuterol 0.15–0.3 mg/kg (maximum 10 mg per dose) via nebulizer every 1–4 hours as needed 1, 2
- Severe exacerbations: Continuous nebulization at 0.5 mg/kg/hour 2
Technical Specifications
- Solution concentration: Use 0.083% albuterol sulfate solution (2.5 mg/3 mL unit-dose vials) 3
- Dilution: No dilution required for unit-dose vials; if using concentrated solution, dilute to minimum 3 mL total volume 1
- Gas flow rate: 6–8 L/min 1
- Driving gas: Oxygen for acutely ill patients; air for stable patients 4
- Delivery method: Mouthpiece or face mask (face mask preferred for acutely breathless patients) 4
Clinical Decision Algorithm
Severity-Based Approach
Mild-to-Moderate Exacerbation (FEV₁ or PEF 40–69% predicted):
- Start with albuterol 2.5 mg (adults) or 0.15 mg/kg (children) every 20 minutes × 3 doses 1
- Reassess after 1 hour; if improved, transition to every 1–4 hours as needed 1
- Consider adding ipratropium 0.5 mg (adults) or 0.25–0.5 mg (children) to each of the first 3 doses for additional benefit 1
Severe Exacerbation (FEV₁ or PEF <40% predicted):
- Use higher doses: albuterol 5 mg (adults) or 0.3 mg/kg (children) every 20 minutes × 3 doses 1
- Add ipratropium bromide 0.5 mg to albuterol for the first 3 doses—this combination provides additional bronchodilation in severe cases 1
- If inadequate response after 1 hour, consider continuous nebulization 1
- Administer systemic corticosteroids concurrently 1
Continuous Nebulization Protocol (for severe/refractory cases):
- Adults: 10–15 mg/hour (equivalent to 2.5 mg every 15 minutes) 1
- Children: 0.5 mg/kg/hour 2
- This approach is safe and as effective as frequent intermittent dosing 5, 6, 7
- Continue until clinical improvement, then transition to intermittent dosing 4
Sample Order Format
"Albuterol 2.5 mg via nebulizer every 20 minutes × 3 doses, then 2.5–5 mg every 1–4 hours as needed for wheezing/shortness of breath. Use oxygen at 6–8 L/min as driving gas. May add ipratropium 0.5 mg to first 3 doses if severe exacerbation."
For pediatric patients, substitute weight-based dosing as outlined above.
Important Caveats
Safety Considerations
- High-dose, frequently administered albuterol is safe with minimal adverse effects (tremor, tachycardia, hypokalemia occur in <5% of patients) 5, 8
- Continuous cardiac monitoring is not routinely required but consider for patients receiving continuous nebulization or those with cardiac comorbidities 7
- Single high doses (7.5 mg) are equivalent to three sequential 2.5 mg doses in efficacy and safety 9
When to Escalate
- Lack of response after 1 hour of aggressive nebulized therapy indicates need for senior clinician review and consideration of additional interventions (IV magnesium, noninvasive ventilation, ICU transfer) 4
- Make admission decision within 4 hours of presentation 1
Transition Strategy
- Switch to metered-dose inhaler (MDI) with spacer (4–8 puffs every 20 minutes × 3, then every 1–4 hours) once patient stabilizes—this is equally effective and may permit earlier discharge 1, 4, 10
- MDI with valved holding chamber is as effective as nebulizer for mild-to-moderate exacerbations when proper technique is used 1
Outpatient Dosing
- For routine outpatient management (not acute exacerbation): 2.5 mg 3–4 times daily, maximum 10 mg/day 3